Strategic and technology alliances enable Genedata to continuously innovate and support emerging experimental technologies. Genedata’s team of dedicated computer and life science experts collaborate with leading organizations to develop and deliver tailored software solutions. Genedata welcomes new opportunities to partner with companies worldwide.

Business Alliances
Developing innovative products through strategic business alliances

AB SCIEX’s global leadership and world-class service and support in the mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide.

Affymetrix technology for analyzing complex genetic information is used by the world's top pharmaceutical, diagnostic, and biotechnology companies, as well as leading academic, government, and nonprofit research institutes.

ChemAxon is a leader in providing Java based chemical software development platforms for the biotechnology and pharmaceutical industries.

Thomson Reuters (formerly GeneGo) develops systems biology technology such as compound-based pathway analysis, and cheminformatics and bioinformatics software for life science research.

Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function.

Ingenuity Systems, a QIAGEN company, is the global leader in applications to quickly analyze and interpret genomic data.

LECO is a leader in innovative analytical instrumentation, mass spectrometers, metallography and optical equipment, and consumables.

Insilico Biotechnology is a market-leading company providing solutions and software for the simulation of living cells. For world-leading companies from the chemical and pharmaceutical industries, Insilico's technology lowers time, risk and costs of development processes.

PerkinElmer Inc. is a global technology leader driving growth and innovation in health sciences and photonics markets to improve the quality of life.

Thermo Fisher Scientific Inc. is the world leader in serving science with products and services that help accelerate the pace of scientific discovery, and solve a wide range of analytical challenges.

Research Consortia
Contributing to cutting-edge research and development

EpiFemCare (FP7) is an oncogenomics project to develop a blood based diagnostic test for early detection of breast and ovarian cancer, based on epigenetic markers. Genedata will analyze NGS and array data to discover and validate tumor specific DNA methylation markers that can be detected in serum.

EXPOsOMICS (FP7) aims to develop a novel approach to the assessment of exposure to high priority environmental pollutants by characterizing the external and the internal components of the exposome. Genedata will process, intergrate and analyse -omics data with internal and external exposure data, to derive molecular events linked to exposure leading to increased disease risk.

BaSysBio, the Bacillus Systems Biology consortium, represents an integrated systems biology project involving 15 research organizations from nine European countries, studying the global regulation of gene transcription in model bacteria.

The BioCop project, a consortia of 33 partners representing 16 EU member states, has been constructed to supply regulators, consumers and industry with long-term solutions to the complex problems associated with chemical contaminant monitoring of foodstuffs.

The European Commission project carcinoGENOMICS is developing in vitro methods for assessing the carcinogenic potential of compounds.

ERANet PathoGenoMicssncRNAomics
A European research consortium using a systems biology approach to investigate the role of small non-coding RNA (sncRNA) in infectious diseases. ERANet provides novel targets for diagnostics and therapy of the five major high-risk gram-positive human microbial pathogens - Staphylococcus, Streptococcus, Enterococcus, Clostridium, and Listeria.

diXa The main objective of the diXa project is to develop and adopt a robust and sustainable service infrastructure (e.g. data infrastructure and e-science environment) for harboring multiplexed data sets as produced by past, current and future EU research projects on developing non-animal tests for predicting chemical safety in linkage with other globally available chemical/toxicological data bases and data bases on molecular data of human disease.

EuRhythDia is a collaborative project funded by the European Commission within the FP7 program. The objective of the project is to achieve breakthroughs in the understanding of the causality between inner clock rhythm disturbances and the development of type 2 diabetes/obesity, and to verify whether re-setting the circadian clock through lifestyle interventions (exercise, diet, light exposure and melatonin intake) alters cardiometabolic risk to a clinically relevant degree. The whole consortium consists of 16 partners from different European Countries.

FRISYS, the Freiburg Initiative for Systems Biology, focuses on modeling and systems analysis of signaling processes in growth and differentiation in human cells and a number of model organisms.

HepatoSys, an interdisciplinary initiative by leading German research centers, aims to understand the physiology and pathophysiology of the human liver cell using a systems biology approach.

INCA, the Infections and Cancer research initiative, focuses on the role of chronic infection in the development of cancer to find new prevention measures and treatments.

InnoMed PredTox
InnoMed PredTox is a joint Industry and European Commission collaboration to improve drug safety. The consortium is composed of 14 major pharmaceutical companies and several academic and commercial institutions providing computational & laboratory resources.

Kluyver Centre for Genomics and Industrial Fermentation
Kluyver Centre is a joint industry and academic consortium that applies genomics technology to improve industrial fermentation.

MedSys – “Dr. Jekyll & Mr. Hyde”
The German Medical Systems Biology Project (MedSys) is a multidisciplinary project led by leading German research centers to identify novel targets for diagnostics, patient risk assessment, and therapy of infectious disease caused by the opportunistic fungal pathogen Candida albicans.

NewGeneris is an integrated EU project investigating the role of prenatal and early-life exposure to genotoxic chemicals present in food and the environment.

The NTC (Netherlands Toxicogenomics Centre) has been initiated by the Netherlands Genomics Initiative. It represents a collaboration of leading knowledge institutes and several companies to identify hazards of chemical compounds and assessing risks of human exposure.

The PROLIGEN consortium studies the regenerative capacity of injured kidneys using information derived from genomics, proteomics, and functional genomics.

Founded and coordinated by the leading specialty chemicals producer Evonik Degussa, the SysMAP consortium exploits novel experimental and computational methods to probe the biological mechanisms underlying industrial fermentation